If your PSA levels are consistently elevated or abnormalities are detected during a urological check-up, further diagnostic tests are necessary.
Based on current guidelines, the European Association of Urology recommends the next step to be a multiparametric MRI (mpMRI) of the prostate. This non-invasive imaging technique helps identify any suspicious areas within the prostate. If a suspicious area is found, a fusion biopsy is recommended.
During a fusion biopsy, samples are taken from the abnormal areas identified on the MRI. Additionally, a standard biopsy is performed during the same procedure, where six samples are systematically taken from each side of the prostate. Fusion biopsy is currently the most advanced diagnostic method available for prostate cancer.
The biopsy is performed transrectally under local anesthesia and typically takes approximately 10-20 minutes.
Further information:
- 2 appointments are required to perform the biopsy
Details of the procedure → - Hochauflösender Mikro-Ultraschall
Use of State-of-the-art Technology →